跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-ketorolac
首页
药物
R-ketorolac
R-ketorolac
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR PREPARING (R)-KETOROLAC AND USE THEREOF
US 20260035372 A1
申请人: YINUOKE MEDICINE SCIENCE AND TECH CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
GALACTOSYLATED PRO-DRUGS OF NON-STEROIDAL ANTI-INFLAMMATORIES WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS AND REDUCED TOXICITY OF THE STARTING DRUG
US 2011212904 A1
申请人: STEWART ITALIA SRL
优先权: 2008
EP
US
3 件公开
Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US 2003191187 A1
申请人: LEE FANG YU
优先权: 2002
US
Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
US 2006183786 A1
申请人: CHI MEI FOUNDATION HOSPITAL
优先权: 2005
US
PHARMACEUTICAL FORMULATION FOR PARENTERAL ADMINISTRATION
US 2010010046 A1
申请人: IRONWOOD PHARMACEUTICALS INC
优先权: 2007
US
Application of Rac1 activity inhibitor in preparation of drugs for treating Alzheimer disease
CN 109925510 A
申请人: BEIJING JOEKAI BIOTECHNOLOGY LLC
优先权: 2019
CN
Salts of R-ketorolac
US 12492206 B2
申请人: UNM RAINFOREST INNOVATIONS
优先权: 2020
US
A COMBINATION OF R-KETOROLAC, BUMETANIDE AND NIFLUMIC
WO 2026047515 A1
申请人: GLIOGUARD S R L
优先权: 2024
WO
药物
反馈